{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:40:07Z","timestamp":1790872807830,"version":"4.1.0"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>To cope with hypoxic stress, ancient organisms have developed evolutionally conserved programs centered on hypoxia-inducible transcriptional factors (HIFs). HIFs and their regulatory proteins have evolved as rheostats to adapt cellular metabolism to atmospheric oxygen fluctuations, but the amplitude of their transcriptional programs has tremendously increased along evolution to include a wide spectrum of physiological and pathological processes. The bone marrow represents a notable example of an organ that is physiologically exposed to low oxygen levels and where basal activation of hypoxia signaling appears to be intrinsically wired within normal and neoplastic hematopoietic cells. HIF-mediated responses are mainly piloted by the oxygen-labile \u03b1 subunits HIF1\u03b1 and HIF2\u03b1, and current literature suggests that these genes have a functional specification that remains to be fully defined. Since their identification in the mid 90s, HIF factors have been extensively studied in solid tumors, while their implication in leukemia has lagged behind. In the last decades however, many laboratories have addressed the function of hypoxia signaling in leukemia and obtained somewhat contradictory results. Suppression of HIFs expression in different types of leukemia has unveiled common leukemia-promoting functions such as stimulation of bone marrow neoangiogenesis, maintenance of leukemia stem cells and chemoresistance. However, genetic studies are revealing that a definition of HIF factors as bona fide tumor promoters is overly simplistic, and, depending on the leukemia subtype, the specific oncogenic event, or the stage of leukemia development, activation of hypoxia-inducible genes may lead to opposite consequences. With this article we will provide an updated summary of the studies describing the regulation and function of HIF1\u03b1 and HIF2\u03b1 in blood malignancies, spanning from acute to chronic, lymphoid to myeloid leukemias. In discussing these data, we will attempt to provide plausible explanations to contradictory findings and point at what we believe are areas of weakness in which further investigations are urgently needed. Gaining additional knowledge into the role of hypoxia signaling in leukemia appears especially timely nowadays, as new inhibitors of HIF factors are entering the clinical arena for specific types of solid tumors but their utility for patients with leukemia is yet to be determined.<\/jats:p>","DOI":"10.3389\/fonc.2022.973978","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T14:18:02Z","timestamp":1660832282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Hypoxic stress and hypoxia-inducible factors in leukemias"],"prefix":"10.3389","volume":"12","author":[{"given":"Daniela","family":"Magliulo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1147949","article-title":"Life with oxygen","volume":"318","author":"Semenza","year":"2007","journal-title":"Science"},{"key":"B2","first-page":"9","article-title":"For their discoveries of how cells sense and adapt to oxygen availability","volume":"1","author":"Kaelin","year":"2019","journal-title":"Nobel Prize."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00029.2010","article-title":"Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans","volume":"25","author":"Taylor","year":"2010","journal-title":"Physiol (Bethesda)."},{"key":"B4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00424-015-1743-z","article-title":"Hypoxia regulates the hematopoietic stem cell niche","volume":"468","author":"Morikawa","year":"2016","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21690","article-title":"Hypoxia or in situ normoxia: The stem cell paradigm","volume":"219","author":"Ivanovic","year":"2009","journal-title":"J Cell Physiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-314427","article-title":"High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq","volume":"117","author":"Sch\u00f6del","year":"2011","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00315.2015","article-title":"Hypoxia-inducible factor 3 biology: Complexities and emerging themes","volume":"310","author":"Duan","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-30338-z","article-title":"Identification of oleoylethanolamide as an endogenous ligand for HIF-3\u03b1","volume":"13","author":"Diao","year":"2022","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.molmet.2020.01.009","article-title":"Genome-wide association study of adipocyte lipolysis in the GENetics of adipocyte lipolysis (GENiAL) cohort","volume":"34","author":"Kulyt\u00e9","year":"2020","journal-title":"Mol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10409238.2013.838205","article-title":"Transcriptional regulation by hypoxia inducible factors","volume":"49","author":"Dengler","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/2021.10.27.466110","article-title":"Mechanisms governing target search and binding dynamics of hypoxia-inducible factors","author":"Chen","year":"2021","journal-title":"bioRxiv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.04.003","article-title":"Understanding the oxygen-sensing pathway and its therapeutic implications in diseases","volume":"190","author":"Liao","year":"2020","journal-title":"Am J Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von hippel-lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von hippel-lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200273200","article-title":"Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family","volume":"277","author":"Hewitson","year":"2002","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068592","article-title":"Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch","volume":"295","author":"Lando","year":"2002","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406026200","article-title":"Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor","volume":"279","author":"Appelhoff","year":"2004","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2016.10.016","article-title":"Hypoxia-inducible factors: Master regulators of cancer progression","volume":"2","author":"Schito","year":"2016","journal-title":"Trends cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nature14883","article-title":"Structural integration in hypoxia-inducible factors","volume":"524","author":"Wu","year":"2015","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"re12","DOI":"10.1126\/stke.3062005re12","article-title":"Integration of oxygen signaling at the consensus HRE","volume":"2005","author":"Wenger","year":"2005","journal-title":"Sci STKE"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201846401","article-title":"Inherent DNA-binding specificities of the HIF-1\u03b1 and HIF-2\u03b1 transcription factors in chromatin","volume":"20","author":"Smythies","year":"2019","journal-title":"EMBO Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2018.1538357","article-title":"HIF-\u03b1 factors as potential therapeutic targets in leukemia","volume":"22","author":"Magliulo","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e06-05-0419","article-title":"The n-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha","volume":"18","author":"Hu","year":"2007","journal-title":"Mol Biol Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: Sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat Rev Cancer."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7543","article-title":"Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia","volume":"166","author":"Narravula","year":"2001","journal-title":"J Immunol"},{"key":"B28","article-title":"Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: Characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-myc","volume":"62","author":"Mazure","year":"2002","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M700534200","article-title":"Hypoxia-inducible factor-1 alpha inhibits self-renewal of mouse embryonic stem cells in vitro via negative regulation of the leukemia inhibitory factor-STAT3 pathway","volume":"282","author":"Jeong","year":"2007","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2010.01.004","article-title":"Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter","volume":"1803","author":"Lee","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.305","article-title":"Epigenetic regulation of HIF-1\u03b1 in renal cancer cells involves HIF-1\u03b1\/2\u03b1 binding to a reverse hypoxia-response element","volume":"31","author":"Xu","year":"2012","journal-title":"Oncogene"},{"key":"B32","doi-asserted-by":"publisher","first-page":"109607","DOI":"10.1016\/j.celrep.2021.109607","article-title":"Macrophage HIF-2\u03b1 suppresses NLRP3 inflammasome activation and alleviates insulin resistance","volume":"36","author":"Li","year":"2021","journal-title":"Cell Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21218320","article-title":"Hypoxic regulation of gene transcription and chromatin: Cause and effect","volume":"21","author":"Kindrick","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2014.1.542","article-title":"The science behind the hypoxic niche of hematopoietic stem and progenitors","volume":"2014","author":"Nombela-Arrieta","year":"2014","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(01)75732-3","article-title":"Modeling pO(2) distributions in the bone marrow hematopoietic compartment. i. krogh\u2019s model","volume":"81","author":"Chow","year":"2001","journal-title":"Biophys J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0701152104","article-title":"Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia","volume":"104","author":"Parmar","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-233437","article-title":"Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: Serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches","volume":"116","author":"Winkler","year":"2010","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2730","article-title":"Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment","volume":"15","author":"Nombela-Arrieta","year":"2013","journal-title":"Nat Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-467498","article-title":"Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: Functional implications on hematopoietic stem cells","volume":"122","author":"Lassailly","year":"2013","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2010.08.004","article-title":"Acquisition of G\u2080 state by CD34-positive cord blood cells after bone marrow transplantation","volume":"38","author":"Shima","year":"2010","journal-title":"Exp Hematol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.11.056","article-title":"Reconstitution activity of hypoxic cultured human cord blood CD34-positive cells in NOG mice","volume":"378","author":"Shima","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2015.0112","article-title":"Hypoxic niche-mediated regeneration of hematopoiesis in the engraftment window is dominantly affected by oxygen tension in the milieu","volume":"24","author":"Moirangthem","year":"2015","journal-title":"Stem Cells Dev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1634\/stemcells.2004-0351","article-title":"Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells","volume":"24","author":"Hermitte","year":"2006","journal-title":"Stem Cells"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17669","article-title":"Expansion of human SCID-repopulating cells under hypoxic conditions","volume":"112","author":"Danet","year":"2003","journal-title":"J Clin Invest."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.23019","article-title":"Combination of low O(2) concentration and mesenchymal stromal cells during culture of cord blood CD34(+) cells improves the maintenance and proliferative capacity of hematopoietic stem cells","volume":"227","author":"Hammoud","year":"2012","journal-title":"J Cell Physiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.exphem.2010.01.005","article-title":"Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture","volume":"38","author":"Eliasson","year":"2010","journal-title":"Exp Hematol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.exphem.2021.02.012","article-title":"Hypoxia promotes erythroid differentiation through the development of progenitors and proerythroblasts","volume":"97","author":"Bapat","year":"2021","journal-title":"Exp Hematol"},{"key":"B50","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2000.02457.x","article-title":"Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes","volume":"111","author":"Mostafa","year":"2000","journal-title":"Br J Haematol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.253","article-title":"ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation","volume":"4","author":"Chen","year":"2013","journal-title":"Cell Death Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(200005)64:1<20::aid-ajh4>3.0.co;2-#","article-title":"Effects of hypoxia on granulocytic-monocytic progenitors in rats. Role of bone marrow stroma","volume":"64","author":"Taneja","year":"2000","journal-title":"Am J Hematol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530050506","article-title":"Improvement of culture conditions for human megakaryocytic and pluripotent progenitor cells by low oxygen tension","volume":"5","author":"Katahira","year":"1987","journal-title":"Int J Cell Cloning."},{"key":"B54","article-title":"Reduced oxygen tension increases hematopoiesis in long-term culture of human stem and progenitor cells from cord blood and bone marrow","volume":"20","author":"Koller","year":"1992","journal-title":"Exp Hematol"},{"key":"B55","article-title":"Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages","volume":"26","author":"LaIuppa","year":"1998","journal-title":"Exp Hematol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00286","article-title":"Non-canonical mechanisms regulating hypoxia-inducible factor 1 alpha in cancer","volume":"7","author":"Iommarini","year":"2017","journal-title":"Front Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2019.1613370","article-title":"The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy","volume":"14","author":"Albadari","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"B58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","article-title":"Regulation of the HIF-1alpha level is essential for hematopoietic stem cells","volume":"7","author":"Takubo","year":"2010","journal-title":"Cell Stem Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0448","article-title":"The HIF family member EPAS1\/HIF-2alpha is required for normal hematopoiesis in mice","volume":"102","author":"Scortegagna","year":"2003","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-161539","article-title":"CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure","volume":"113","author":"Fiegl","year":"2009","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1182\/blood.V99.1.394","article-title":"Oxygen saturation in the bone marrow of healthy volunteers","volume":"99","author":"Harrison","year":"2002","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2184.2000.00183.x","article-title":"Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats","volume":"33","author":"Jensen","year":"2000","journal-title":"Cell Prolif"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00991","article-title":"Inhibition of oxidative phosphorylation reverses bone marrow hypoxia visualized in imageable syngeneic b-ALL mouse model","volume":"10","author":"Rytelewski","year":"2020","journal-title":"Front Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-657056","article-title":"HIF-1\u03b1 regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment","volume":"127","author":"Valsecchi","year":"2016","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.217430","article-title":"HIF-1\u03b1 is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia","volume":"105","author":"Griggio","year":"2020","journal-title":"Haematologica"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.3390\/cancers13122883","article-title":"Targeting HIF-1\u03b1 regulatory pathways as a strategy to hamper tumor-microenvironment interactions in CLL","volume":"13","author":"Vitale","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin","volume":"100","author":"Mayerhofer","year":"2002","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-014-0434-2","article-title":"HIF-\u03b1 promotes chronic myelogenous leukemia cell proliferation by upregulating p21 expression","volume":"72","author":"Chen","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.102","article-title":"Hypoxia inducible factor (HIF)-2\u03b1 accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML","volume":"29","author":"Forristal","year":"2015","journal-title":"Leukemia"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.56","article-title":"AML1\/ETO cooperates with HIF1\u03b1 to promote leukemogenesis through DNMT3a transactivation","volume":"29","author":"Gao","year":"2015","journal-title":"Leukemia"},{"key":"B72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.leukres.2016.11.014","article-title":"mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia","volume":"53","author":"Kontos","year":"2017","journal-title":"Leuk Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-185686","article-title":"Aberrant regulation of pVHL levels by microRNA promotes the HIF\/VEGF axis in CLL b cells","volume":"113","author":"Ghosh","year":"2009","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0280-0","article-title":"Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients","volume":"33","author":"Manso","year":"2019","journal-title":"Leukemia"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403332","article-title":"Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF","volume":"18","author":"Wellmann","year":"2004","journal-title":"Leukemia"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.20838","article-title":"Regulation of HIF-1\u03b1 signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment","volume":"13","author":"Frolova","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.119","article-title":"Integration of hypoxic HIF-\u03b1 signaling in blood cancers","volume":"36","author":"Schito","year":"2017","journal-title":"Oncogene"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1201-z","article-title":"Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1\u03b1 with echinomycin","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2174\/1871520619666191211101357","article-title":"Association of GRP78, HIF-1\u03b1 and BAG3 expression with the severity of chronic lymphocytic leukemia","volume":"20","author":"Ijabi","year":"2020","journal-title":"Anticancer Agents Med Chem"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.648808","article-title":"The interplay between tumor suppressor p53 and hypoxia signaling pathways in cancer","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0513-x","article-title":"Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL","volume":"34","author":"Yosifov","year":"2020","journal-title":"Leukemia"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133187","article-title":"Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia","volume":"130","author":"Waclawiczek","year":"2020","journal-title":"J Clin Invest"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.20-4-347","article-title":"Hypoxia modifies proliferation and differentiation of CD34(+) CML cells","volume":"20","author":"Desplat","year":"2002","journal-title":"Stem Cells"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2013-0166","article-title":"A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: A new tool to decipher their chemoresistance and self-renewal mechanisms","volume":"3","author":"Griessinger","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-511907","article-title":"Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-387381","article-title":"HIF1\u03b1 is required for survival maintenance of chronic myeloid leukemia stem cells","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"B87","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","article-title":"Targeting HIF1\u03b1 eliminates cancer stem cells in hematological malignancies","volume":"8","author":"Wang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-745588","article-title":"Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine","volume":"130","author":"Cheloni","year":"2017","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3892\/ol.2021.12953","article-title":"Effects of hypoxia on DNA hydroxymethylase tet methylcytosine dioxygenase 2 in a KG-1 human acute myeloid leukemia cell line and its mechanism","volume":"22","author":"He","year":"2021","journal-title":"Oncol Lett"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201303065","article-title":"HIF factors cooperate with PML-RAR\u03b1 to promote acute promyelocytic leukemia progression and relapse","volume":"6","author":"Coltella","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-8722-6-3","article-title":"Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells","volume":"6","author":"Zou","year":"2013","journal-title":"J Hematol Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-609370","article-title":"Leukemia stem cells in T-ALL require active Hif1\u03b1 and wnt signaling","volume":"125","author":"Giambra","year":"2015","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10660","article-title":"Hypoxia inducible factor-1\u03b1 regulates a pro-invasive phenotype in acute monocytic leukemia","volume":"7","author":"Migliavacca","year":"2016","journal-title":"Oncotarget"},{"key":"B94","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13073-014-0084-4","article-title":"A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia","volume":"6","author":"Percio","year":"2014","journal-title":"Genome Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3892\/ol.2020.12359","article-title":"Hypoxic exposure activates the b cell-specific moloney murine leukaemia virus integration site 1\/PI3K\/Akt axis and promotes EMT in leukaemia stem cells","volume":"21","author":"Jiang","year":"2021","journal-title":"Oncol Lett"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00332-6","article-title":"Linking EMT programmes to normal and neoplastic epithelial stem cells","volume":"21","author":"Lambert","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B97","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/bloodadvances.2016000984","article-title":"Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment","volume":"1","author":"Serra","year":"2016","journal-title":"Blood Adv"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4006","article-title":"Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells","volume":"6","author":"Rigoni","year":"2015","journal-title":"Oncotarget"},{"key":"B99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40170-019-0206-y","article-title":"HIF1\/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem\/progenitor cells","volume":"7","author":"Wierenga","year":"2019","journal-title":"Cancer Metab"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.08.011","article-title":"HIF-2\u03b1 protects human hematopoietic Stem\/Progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"Rouault-Pierre","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B101","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12885-016-2776-1","article-title":"Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways","volume":"16","author":"Petit","year":"2016","journal-title":"BMC Cancer."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002832","article-title":"Hypoxia favors chemoresistance in T-ALL through an HIF1\u03b1-mediated mTORC1 inhibition loop","volume":"5","author":"Fahy","year":"2021","journal-title":"Blood Adv"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.02.028","article-title":"Elevated HIF-1\u03b1 expression of acute myelogenous leukemia stem cells in the endosteal hypoxic zone may be a cause of minimal residual disease in bone marrow after chemotherapy","volume":"36","author":"Matsunaga","year":"2012","journal-title":"Leuk Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2165\/00003495-200767020-00010","article-title":"Imatinib: a review of its use in chronic myeloid leukaemia","volume":"67","author":"Moen","year":"2007","journal-title":"Drugs"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.67","article-title":"Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming","volume":"29","author":"Zhao","year":"2010","journal-title":"Oncogene"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3892\/etm.2021.10503","article-title":"MicroRNA-18a-5p regulates the warburg effect by targeting hypoxia-inducible factor 1\u03b1 in the K562\/ADM cell line","volume":"22","author":"Wu","year":"2021","journal-title":"Exp Ther Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"190262","DOI":"10.1098\/rsob.190262","article-title":"EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine","volume":"10","author":"Valsecchi","year":"2020","journal-title":"Open Biol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00544-5","article-title":"Belzutifan: a novel therapy for von hippel\u2013lindau disease","volume":"18","author":"Zhou","year":"2022","journal-title":"Nat Rev Nephrol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.3390\/cancers13184518","article-title":"The tumor microenvironment-dependent transcription factors AHR and HIF-1\u03b1 are dispensable for leukemogenesis in the e\u00b5-TCL1 mouse model of chronic lymphocytic leukemia","volume":"13","author":"Gonder","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-567065","article-title":"HIF-1\u03b1 can act as a tumor suppressor gene in murine acute myeloid leukemia","volume":"124","author":"Velasco-Hernandez","year":"2014","journal-title":"Blood"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.11.023","article-title":"Hif-1\u03b1 deletion may lead to adverse treatment effect in a mouse model of MLL-AF9-Driven AML","volume":"12","author":"Velasco-Hernandez","year":"2019","journal-title":"Stem Cell Rep"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20150452","article-title":"Hif-1\u03b1 and hif-2\u03b1 synergize to suppress AML development but are dispensable for disease maintenance","volume":"212","author":"Vukovic","year":"2015","journal-title":"J Exp Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.973978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T22:41:09Z","timestamp":1700952069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.973978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":113,"alternative-id":["10.3389\/fonc.2022.973978"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.973978","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"article-number":"973978"}}